CELL AND GENE THERAPY FOR ONCOLOGY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)
The global cell and gene therapy for oncology market is estimated to be valued at USD 8,641.9 Mn in 2026 and is expected to reach USD 138,425.0 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 44.7% from 2026 to 2033. The market for global cell and gene therapy for oncology is among the fastest-growing markets in the field of oncology therapeutics due to the growing number of cancers and the increasing need for personalized and targeted therapeutic solutions. The major firms engaged in this field are striving to develop state-of-the-art treatments such as CAR-T, TCR, and genetically engineered immunotherapy that provide better results than existing therapies.
The technological progress in gene editing, development of viral vectors, and cell engineering technologies is revolutionizing the cancer therapy process. There are several other factors contributing to the market's growth such as increased participation in clinical trials, approvals, and financial investments by biopharmaceutical companies. Moreover, rising use of precision medicine, improvements in production, and strategic partnerships are driving innovation in the cell and gene-based cancer treatment market.
Market Dynamics
The global cell and gene therapy for oncology market is spurred by an increasing burden of cancer across the globe and an increasing demand for oncology treatments that offer greater precision. Increased public awareness about new cancer therapies, coupled with advances made in techniques like CAR-T cell therapy, gene-editing, and viral vectors, is further boosting the growth of the market. Moreover, an increased number of clinical trials and investment in innovative oncology treatments by major players in biopharmaceuticals can be seen.
Some of the factors restricting the growth of the market include the high costs associated with oncology cell and gene therapy, the high costs of production, and stringent regulatory frameworks for the same. Safety issues related to the adverse side effects of such procedures, such as cytokine release syndrome, also present themselves. Nevertheless, there are ample opportunities for growth within the market, owing to the rise of allogenic and off-the-shelf therapies, wider applications for solid tumors, and increased investments in manufacturing facilities.
Key Features of the Study
Market Segmentation
Market Segmentation
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
